Deargen Company
Deargen provides AI-based genome analysis service.
Technology:
COVID
Industry:
AI, End-to-end Drug Development
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2016-12-06
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
19647275
Last Funding Date:
2022-02-24
Last Funding Type:
Series B
Register and Claim Ownership